BRNS logo

Barinthus Biotherapeutics plc (BRNS)

Profile

Full Name

Barinthus Biotherapeutics plc

Ticker

NASDAQ: BRNS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

April 30, 2021

Indexes

Not included

Website

https://www.barinthusbio.com

Employees

105

Key Details

Price

$1.05(-4.55%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$14.98M(+1760.05% YoY)

Annual EPS

-$1.55(+19.12% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.05
    BRNS price is $1.05

    30-Day Relative Volume

    1.60
    BRNS 30-day relative volume is 1.60

    Price Performance

    Price Most recent change

    -4.55%
    BRNS price was down -4.55% on Sep 15, 2025

    Price YTD change

    -13.08%
    BRNS price is down -13.08% since January 1st

    Price 1-year change

    -17.32%
    BRNS price is down -17.32% year-on-year

    Price 3-year change

    -69.91%
    BRNS price is down -69.91% over the past 3 years

    Price Range

    Price All-time high

    $17.99
    BRNS price is currently -94.16% below its historical high of $17.99

    Price 3-year low

    $0.64
    BRNS price is currently +64.06% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $42.75M
    BRNS market capitalization is $42.75 million

    Market cap 3-year change

    -67.08%
    BRNS market capitalization is down -67.08% over the past 3 years

    Market cap All-time high

    $579.09M
    BRNS market capitalization is currently -92.62% below its historical high of $579.09 million

    Market cap sector rank

    30.2%
    BRNS market capitalization is higher than 30.2% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.31%
    BRNS shares outstanding is up +3.31% year-on-year

    Shares Outstanding 3-Year Change

    +9.41%
    BRNS shares outstanding is up +9.41% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.67
    BRNS beta is 0.67

    200-day SMA

    $1.04
    BRNS price is currently +0.92% above its 200-day simple moving average

    50-day SMA

    $1.29
    BRNS price is currently -18.52% below its 50-day simple moving average

    RSI

    40.31
    BRNS 14-day relative strength index is 40.31

    Volume

    1.60
    BRNS 30-day relative volume is 1.60

    ATR

    $0.12
    BRNS average true range is $0.12

    10-day Historical Volatility

    82.48%
    BRNS 10-day historical volatility is 82.48%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $14.98M
    BRNS annual revenue is $14.98 million

    Revenue Analysts estimate

    -
    BRNS annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    +1760.05%
    BRNS annual revenue is up +1760.05% year-on-year

    Revenue Sector rank

    51.25%
    BRNS annual revenue is higher than 51.25% of companies in Healthcare sector

    EPS

    EPS

    -$1.55
    BRNS annual earnings per share is -$1.55

    EPS Analysts estimate

    -$1.64
    BRNS annual earnings per share is currently -5.64% lower than the consensus analysts' forecast

    EPS 1-year change

    +19.12%
    BRNS annual earnings per share is up +19.12% year-on-year

    EPS Sector rank

    41.81%
    BRNS annual earnings per share is higher than 41.81% of companies in Healthcare sector

    Profit

    Gross profit

    $9.17M
    BRNS annual gross profit is $9.17 million

    Gross margin

    61.25%
    BRNS annual gross profit margin is 61.25%

    Operating profit

    -$55.43M
    BRNS annual operating income is -$55.43 million

    Operating margin

    -370.12%
    BRNS annual operating profit margin is -370.12%

    Net income

    -$61.21M
    BRNS annual net profit is -$61.21 million

    Net margin

    -408.73%
    BRNS annual net profit margin is -408.73%

    Expenses

    Total expenses

    $76.08M
    BRNS annual total expenses is $76.08 million

    Operating expenses

    $64.60M
    BRNS annual total operating expenses is $64.60 million

    Cost of goods sold

    $5.80M
    BRNS annual cost of goods sold is $5.80 million

    Selling, general & administrative expenses

    $0.00
    BRNS annual SGA is $0.00

    Depreciation and amortization

    $5.80M
    BRNS annual depreciation & amortization is $5.80 million

    Interest expense

    $0.00
    BRNS annual interest expense is $0.00

    Income tax

    -$4.03M
    BRNS annual income tax is -$4.03 million

    EBIT & EBITDA

    EBIT

    -$55.43M
    BRNS annual earnings before interest & taxes is -$55.43 million

    EBITDA

    -$49.62M
    BRNS annual EBITDA is -$49.62 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $170.14M
    BRNS annual total assets is $170.14 million

    Non current assets

    $34.59M
    BRNS annual long term assets is $34.59 million

    Current assets

    $125.74M
    BRNS annual total current assets is $125.74 million

    Cash and cash equivalents

    $110.66M
    BRNS annual cash & cash equivalents is $110.66 million

    Accounts receivable

    -
    BRNS annual accounts receivable value is unknown

    Inventory

    $0.00
    BRNS annual inventory is $0.00

    Liabilities

    Total liabilities

    $40.01M
    BRNS annual total liabilities is $40.01 million

    Long term liabilities

    $14.54M
    BRNS annual total long term liabilities is $14.54 million

    Current liabilities

    $15.66M
    BRNS annual total current liabilities is $15.66 million

    Accounts payable

    $2.47M
    BRNS annual accounts payable is $2.47 million

    Debt

    Total debt

    $12.01M
    BRNS annual total debt is $12.01 million

    Total debt 1-year change

    -7.47%
    BRNS annual total debt is down -7.47% year-on-year

    Long term debt

    $10.09M
    BRNS annual long term debt is $10.09 million

    Short term debt

    $1.92M
    BRNS annual short term debt is $1.92 million

    Equity & Capital

    Shareholders equity

    $130.03M
    BRNS annual stockholders equity is $130.03 million

    Book value

    $130.03M
    BRNS annual book value is $130.03 million

    Retained earnings

    -$237.66M
    BRNS annual retained earnings is -$237.66 million

    Working capital

    $110.08M
    BRNS annual working capital is $110.08 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$28.95M
    BRNS annual cash flow from operations is -$28.95 million

    Cash from operations 1-year change

    +43.37%
    BRNS annual cash flow from operations is up +43.37% year-on-year

    Cash from investing

    -$892.40K
    BRNS annual cash flow from investing activities is -$892.40 thousand

    Cash from investing 1-year change

    +83.58%
    BRNS annual cash flow from investing activities is up +83.58% year-on-year

    Cash from financing

    $2.16M
    BRNS annual cash flow from financing activities is $2.16 million

    Cash from financing 1-year change

    +15.14%
    BRNS annual cash flow from financing activities is up +15.14% year-on-year

    CAPEX

    CAPEX

    $892.40K
    BRNS annual capital expenditures is $892.40 thousand

    CAPEX 1-year change

    -83.58%
    BRNS annual capital expenditures is down -83.58% year-on-year

    Free Cash Flow

    Free cash flow

    -$29.84M
    BRNS annual free cash flow is -$29.84 million

    Free cash flow 1-year change

    +47.23%
    BRNS annual free cash flow is up +47.23% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    61.25%
    BRNS annual gross profit margin is 61.25%

    Operating margin

    -370.12%
    BRNS annual operating profit margin is -370.12%

    Net margin

    -408.73%
    BRNS annual net profit margin is -408.73%

    ROA & ROE

    ROA

    -30.93%
    BRNS annual return on assets is -30.93%

    ROE

    -38.60%
    BRNS annual return on equity is -38.60%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BRNS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BRNS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.42
    BRNS price to book ratio is 0.42

    PB ratio Sector rank

    23.15%
    BRNS price to book ratio is higher than 23.15% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.83
    BRNS price to sales ratio is 2.83

    PS ratio Sector rank

    44.06%
    BRNS price to sales ratio is higher than 44.06% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    -$33.04M
    BRNS enterprise value is -$33.04 million

    Enterprise value Sector rank

    3.21%
    BRNS enterprise value is higher than 3.21% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.53
    BRNS EV/EBITDA is 0.53

    EV/EBITDA Sector rank

    71.51%
    BRNS EV/EBITDA is higher than 71.51% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    8.03
    BRNS annual current ratio is 8.03

    Quick ratio

    8.03
    BRNS annual quick ratio is 8.03

    Leverage

    Debt to equity

    0.09
    BRNS annual debt to equity ratio is 0.09

    Interest coverage ratio

    -
    BRNS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    BRNS piotroski f-score value is unknown

    Altman Z-Score

    -1.52
    BRNS altman z-score is -1.52

    Analyst ratings

    Recent major analysts updates

    Mar 21, 25 HC Wainwright & Co.
    Buy
    Jan 13, 25 HC Wainwright & Co.
    Buy
    Nov 19, 24 HC Wainwright & Co.
    Buy
    Nov 8, 24 HC Wainwright & Co.
    Buy
    Oct 1, 24 HC Wainwright & Co.
    Buy
    Sep 26, 24 HC Wainwright & Co.
    Buy
    Aug 13, 24 Alliance Global Partners
    Buy
    Aug 12, 24 HC Wainwright & Co.
    Buy
    Jun 13, 24 Barclays
    Overweight
    Jun 7, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with BRNS included

    Growing Shares Outstanding
    UK stocks
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Barinthus Biotherapeutics plc?
    • Does Barinthus Biotherapeutics plc pay dividends?
    • What sector is Barinthus Biotherapeutics plc in?
    • What industry is Barinthus Biotherapeutics plc in?
    • What country is Barinthus Biotherapeutics plc based in?
    • When did Barinthus Biotherapeutics plc go public?
    • Is Barinthus Biotherapeutics plc in the S&P 500?
    • Is Barinthus Biotherapeutics plc in the NASDAQ 100?
    • Is Barinthus Biotherapeutics plc in the Dow Jones?
    • When was Barinthus Biotherapeutics plc's last earnings report?
    • When does Barinthus Biotherapeutics plc report earnings?

    What is the ticker symbol for Barinthus Biotherapeutics plc?

    The ticker symbol for Barinthus Biotherapeutics plc is NASDAQ:BRNS

    Does Barinthus Biotherapeutics plc pay dividends?

    No, Barinthus Biotherapeutics plc does not pay dividends

    What sector is Barinthus Biotherapeutics plc in?

    Barinthus Biotherapeutics plc is in the Healthcare sector

    What industry is Barinthus Biotherapeutics plc in?

    Barinthus Biotherapeutics plc is in the Biotechnology industry

    What country is Barinthus Biotherapeutics plc based in?

    Barinthus Biotherapeutics plc is headquartered in United Kingdom

    When did Barinthus Biotherapeutics plc go public?

    Barinthus Biotherapeutics plc's initial public offering (IPO) was on April 30, 2021

    Is Barinthus Biotherapeutics plc in the S&P 500?

    No, Barinthus Biotherapeutics plc is not included in the S&P 500 index

    Is Barinthus Biotherapeutics plc in the NASDAQ 100?

    No, Barinthus Biotherapeutics plc is not included in the NASDAQ 100 index

    Is Barinthus Biotherapeutics plc in the Dow Jones?

    No, Barinthus Biotherapeutics plc is not included in the Dow Jones index

    When was Barinthus Biotherapeutics plc's last earnings report?

    Barinthus Biotherapeutics plc's most recent earnings report was on August 7, 2025

    When does Barinthus Biotherapeutics plc report earnings?

    The date for Barinthus Biotherapeutics plc's next earnings report has not been announced yet
    On this page